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Background and Purpose: Swallowing difficulties are common post-stroke. 
National clinical guidelines recommend feeding by percutaneous endoscopic 
gastrostomy (PEG) when oral nutrition cannot be maintained although survival 
benefit might be short-term. It is unknown whether a decade of general care 
improvements have impacted upon PEG provision and outcomes. This retrospective 
cohort study examined PEG placement and mortality post-stroke in England.  
Methods: National Health Service Hospital Episode Statistics and Office for National 
Statistics mortality data between April 2007 and March 2018 were linked to identify 
all admissions in England with stroke-related ICD10 codes (I61, I63 and I64) +/- PEG 
insertion and deaths at 3, 6 and 12 months. Linear and logistic regression examined 
trends over time and mortality.  
Results:  923,236 stroke patients underwent 17,532 PEG procedures (mean rate 
1.9%), with an average reduction of -27 procedures/year (95%CI -56 to 1.4; p=0.06) 
despite an average increase of 1804 stroke admissions/year. Mortality decreased 
amongst cases without a PEG procedure: -190 deaths/year (95%CI -276 to -104; 
p<0.001) at 3 months, -167 deaths/year (95%CI -235 to -98; p<0.001) at 6 months 
and -103 deaths/year (95%CI -157 to -50; p<0.01) at 12 months; and also reduced 
following PEG insertion: -28 deaths/year (95%CI -35 to -20; p<0.001) at 3 months, -
33 deaths/year (95%CI -46 to -20; p<0.01) at 6 months and -30 deaths/year (95%CI 
-48 to -13; p<0.01) at 12 months. With all years combined, PEG insertion was weakly 
associated with reduced mortality at 3 months (OR 0.94; 95%CI 0.90 to 0.97), but 
significantly higher mortality at 6 months (OR 1.69; 95%CI 1.64 to 1.75) and 12 
months (OR 2.14; 95%CI 2.08 to 2.20). 
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Conclusion: PEG procedures and subsequent deaths have decreased in the 
context of general mortality reductions following hospitalisation for stroke, but 
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Dysphagia affects approximately half of all acute stroke admissions and is 
associated with a poorer outcome [1,2]. Both UK and US clinical guidelines 
recommend that feeding by percutaneous endoscopic gastrostomy (PEG) should be 
considered if oral nutrition cannot be maintained by 3 to 4 weeks [3,4]. Although trial 
evidence has shown that PEG feeding is associated with fewer feeding failures and 
pressure sores, there is no statistically significant change in dependency or long-
term mortality [5].  
Stroke mortality rates have fallen significantly in the past decade [2,6], reflecting 
improved delivery of evidence-based care which includes pro-active identification 
and treatment of dysphagia [2,3,7]. It is feasible that more patients are surviving the 
acute phase of stroke with long-term swallowing difficulties, thereby increasing the 
demand for non-oral feeding. As no new trial evidence has been reported since 2006 
[1,4,5], it is also unknown whether overall improvements in prognosis following 
stroke have led to a better outlook for patients following PEG insertion.  
 
In this context, we performed a retrospective analysis of routinely collected 
healthcare data across English stroke services to examine: 
1. population level trends over time in PEG procedures after stroke  
2. key demographic associations with PEG insertion   





Finished stroke admission episodes in England (International Classification of 
Diseases (ICD) 10 codes: I61 (haemorrhagic), I63 (ischaemic) and I64 (cause not 
specified)) with and without subsequent PEG insertion (Office of Population 
Censuses and Surveys v4 code: G445) were identified from National Health Service 
Hospital Episode Statistics for financial years between April 2007 and March 2018 
[8]. Demographic data items were limited to gender (female/male), age (<60 years; 
60-79 years; 80+ years) and ethnicity. Cases were linked to Office for National 
Statistics mortality records at 3, 6 and 12 months after admission [9]. All data 
reported were re-used with permission from the national healthcare data controller 
NHS Digital. Ethical review was not required due to regulator permitted use of 
population level routine data sources lacking personal identifying or sensitive 
information. Under conditions imposed by NHS Digital, it is not permitted for the 
authors to share data with other researchers and enquiries should be made through 
https://digital.nhs.uk/services/data-access-request-service-dars.  
 
Linear regression was used to describe time trends in PEG procedures and 
mortality. Cases with missing demographic data were still included in the analysis. 
Logistic regression calculated odds ratios (OR) to examine associations between 
demographic characteristics (age, gender, ethnicity and ICD10 code) and PEG 
insertion. A standard alpha of 0.05 was chosen to indicate statistical significance. 
Regression models were evaluated using standard approaches and assumptions for 
linear regression (multicollinearity, normality of residuals, homoscedasticity, Durbin-
Watson value) and logistic regression (linearity of logit, multicollinearity, 





Over eleven years, there were 923,838 stroke admissions in England with a mean 
increase of 1804 admissions per year (95% CI: 1257 to 2129, p<0.0001). Stroke 
aetiology was coded as ischaemic (I63), haemorrhagic (I61) and unspecified (I64) for 
669,088 (72.4%), 133,405 (14.4%) and 121,345 (13.1%) of cases respectively. The 
majority of patients were aged over 60 years (< 60 years: 136,721 (14.8%); 60-79 
years: 393,125 (42.6%); 80+ years: 391,612 (42.4%); age missing 2380 (0.3%)) and 
Caucasian (774,992 (83.9%); non-Caucasian 63,505 (6.9%); ethnicity missing 
85,431 (9.2%)). Gender distribution was equal (female 465,462 (50.4%); male 
458,315 (49.6%); gender missing 61 (0.1%)). Due to insufficient identification 
information it was not possible to confirm whether a PEG procedure had been 
performed for 602 admissions, which were subsequently excluded from further 
analysis. Yearly counts that did (n=17,532) and did not (n=905,704) undergo PEG 
insertion and corresponding mortality rates are shown in Table 1 and Figure 1.  
 
PEG procedures 
Over 11 years there were 17,532 PEG procedures recorded, a mean of 1594 (SD 
147) annually and an overall rate of 1.9%. The procedure rate fell from 2.3% in 
2007/08 to 1.4% in 2017/18, although it is possible that this final year was affected 
by a lag in service activity reporting. An average absolute reduction of -27 
procedures/year (95%CI -56 to 1.4; p=0.06) was observed despite annual increases 
in stroke admission volume. If PEG rates had remained static from 2007/08 (i.e. 




Characteristics associated with PEG procedures 
Annual admission numbers in key demographic subgroups are shown in 
Supplemental Tables I and II according to PEG insertion status. Logistic regression 
analysis showed that relative to age <60 years, PEG insertion had a positive 
association with patient age 60-79 years (OR 1.97; 95%CI 1.86 to 2.09) and 80+ 
years (OR 2.73; 95%CI 2.58 to 2.90). There was also a positive association with 
female relative to male gender (OR 1.10; 95%CI 1.08 to 1.14), whereas PEG 
insertion was less likely for patients of Caucasian ethnicity (OR 0.88; 95%CI 0.83 to 




Table 1 and Figure 2 show that mortality consistently decreased at all time points 
after stroke irrespective of PEG status. Amongst patients without a PEG procedure 
there were statistically significant reductions of -190 deaths/year (95%CI -276 to -
104; p<0.001; R squared 0.62) at 3 months, -167 deaths/year (95%CI -235 to -98; 
p<0.001; R squared 0.69) at 6 months and -103 deaths/year (95%CI -157 to -50; 
p<0.01; R squared 0.73) at 12 months. These reductions equated to mean annual 
decreases in the death rate at 3, 6 and 12 months of -1.7% (190/17,777), -0.8% 
(167/20,982) and -0.4% (103/24,889).  
 
For patients with PEG placement, mortality fell by -28 deaths/year (95%CI -35 to -20; 
p<0.001; R squared 0.57) at 3 months, -33 deaths/year (95%CI -46 to -20; p<0.01; R 
squared 0.53) at 6 months and -30 deaths/year (95%CI -48 to -13; p<0.01; R 
squared 0.46) at 12 months. These reductions equated to mean annual decreases in 
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the death rate at 3, 6 and 12 months of -9.4% (28/299), -5.7% (33/584) and -3.9% 
(30/766). 
 
When all years were included, PEG insertion was weakly associated with a mortality 
reduction at 3 months (OR 0.94; 95%CI 0.90 to 0.97), but with significantly higher 
mortality at 6 months (OR 1.69; 95%CI 1.64 to 1.75) and 12 months (OR 2.14; 
95%CI 2.08 to 2.20).   
 
DISCUSSION 
Between 2007 and 2018 there was a small but steady decline in PEG procedures 
across English stroke services in the context of significant post-stroke mortality 
reductions. The positive impact of general improvements in stroke care on patient 
outcomes during this period has already been documented [6,10], but a reduction in 
PEG insertions has not previously been reported. Explanations could include 
avoidance of severe neurological impairment for selected patients due to increasing 
use of emergency reperfusion therapies, greater availability of speech therapists and 
trained nursing staff to support modified oral feeding approaches amongst dysphagic 
patients who might have previously remained nil by mouth [11, 12], longer periods of 
nasogastric tube use before permanent enteral feeding is considered and / or a shift 
towards more in-depth discussion with dysphagic patients and families regarding the 
balance between a reduced risk of aspiration from non-oral feeding versus the 
poorer quality of life reported by some individuals reliant upon PEG nutrition. The 
growth in stroke admissions observed during the 11 year interval might also reflect a 
trend towards increased recognition and hospitalisation of milder stroke patients who 
were less likely to require non-oral feeding. However, this is unlikely to be the only 
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explanation because PEG procedures continued to decline even though the largest 
increase in admissions occurred during the first 6 years. 
 
There are limited international data available for comparison of PEG use post-stroke. 
An evaluation of United States healthcare data between 2001 to 2011 revealed an 
average PEG rate of 3.6% amongst 967,119 patients within 30 days of ischaemic 
stroke [12]. Although higher than the English average rate of 1.9%, half of the US 
study pre-dated publication of key evidence informing clinical guidelines [5]. Data 
were not presented regarding US longitudinal trends for PEG insertion, but 53.5% 
took place within 7 days of admission without significant variation in this proportion 
over 10 years, suggesting a more pro-active approach than is proposed by current 
national guidelines. A similar procedure rate of 3.05% was reported amongst 3,504 
Australian stroke admissions during an examination of PEG outcomes between 
January 2005 and December 2013 [13]. However, this cohort represented only two 
metropolitan hospitals, and no information was presented describing local criteria for 
PEG insertion. The lower rate observed in England may reflect international 
differences in clinical guidelines and audit processes to promote compliance, 
variations in cultural views about quality of life and the availability of carers with skills 
for supporting non-PEG feeding amongst dysphagic patients. Adherence to clinical 
guidelines and understanding variations between settings would be facilitated by 
agreement of an internationally standardised post-stroke nutrition dataset which links 
demographic and clinical information (e.g. stroke type and severity) with oral (e.g. 




Consistent with previous reports, we found that PEG insertion was commoner 
amongst older patients [1,5,12,13,14] and females [12,13]. Increasing age is linked 
to greater stroke severity but also reflects accumulation of non-stroke co-morbidities 
that increase the background risk of aspiration (e.g. Parkinsonism) and/or reduce 
adherence to a modified oral feeding regimen (e.g. cognitive impairment) [13,14]. 
The weaker positive association with female gender may reflect a previously 
reported observation that mean age is higher than men at the time of a first stroke 
[15], and consequently women may have a greater frequency of pre-existing 
swallowing difficulties due to the effect of aging and/or age-related comorbidities. 
Ethnic variations in stroke aetiology and subtype have already been recognised 
which might change the frequency of severe dysphagia and requirement for non-oral 
feeding [16], thereby providing a possible explanation for the positive association 
found with non-Caucasian race. However, it is less clear why haemorrhagic stroke is 
associated with fewer PEG procedures than ischaemic stroke when these vascular 
aetiologies can produce similar impairments. It may reflect a different early prognosis 
amongst individuals with haemorrhage or associated clinical characteristics that 
might influence the decision to initiate long term non-oral feeding, such as cognitive 
impairment due to amyloid angiopathy. Further research is required to understand 
these demographic and clinical associations, employing comprehensive data capture 
processes.  
 
Improvements in survival following PEG placement are likely to reflect the same 
trend observed across the general stroke population due to measures such as better 
provision of secondary prevention, but another explanation could be a growing 
tendency to preferentially select dysphagic patients with a more promising outlook. 
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Descriptive US data over a decade shows a minor trend towards younger stroke 
patients being favoured for PEG placement with a mean (SD) age of 76.3 (11.7) 
years in 2001 falling to 74.1 (13.3) years in 2011, but there was a parallel increase in 
comorbidities in this group from a mean (SD) Charlson Comorbidity Index of 1.36 
(1.36) to 2.05 (1.92) [12]. In our UK cohort, the proportion of patients aged 80+ years 
with a PEG fell from 54.3% to 45.7% between 2007 and 2018 in the context of a 
smaller reduction from 43.7% to 40.8% amongst admissions without a PEG 
(Supplemental Table I and II), but no additional clinical data were available. 
Understanding the underlying mechanisms for better survival post-PEG would 
require a mixed methods approach with relevant clinical data collection and 
qualitative examination of practitioner and public preferences over a range of non-
oral feeding scenarios. 
 
The overall pattern observed for short, medium and long-term survival following PEG 
placement was similar to findings from the ‘Feed Or Ordinary Diet’ (FOOD) trial [17]. 
Published in 2005, this influential trial showed no initial difference in mortality when 
321 dysphagic patients were randomised to PEG or nasogastric tube, but by 6 
months the PEG group had experienced 49% (79/162) mortality and a statistically 
significant increased risk of death or poor outcome. Similarly, in a retrospective 
community cohort study, 54% of 174 US stroke patients died within 6 months of PEG 
tube placement [18]. Our cohort has shown that this mortality trend continues at 12 
months. The high rate of poor outcomes for stroke patients following PEG placement 
is likely to reflect an ongoing risk of aspiration and the general health of patients with 
persistent dysphagia, who remain susceptible to other complications associated with 
severe stroke such as pulmonary embolism. Australian stroke patients surviving 
11 
 
beyond 6 months with a PEG in situ were more likely to be younger, have better 
overall health (lower American Society of Anesthesia score) and have a higher 
serum albumin level pre-insertion [13].  It was an unexpected finding in our cohort 
that PEG placement was weakly associated with a survival advantage at 3 months 
after stroke, but it is important to recognise that this group comprised dysphagic 
survivors from the acute phase who were subsequently judged to have a prognosis 
justifying initiation of permanent non-oral feeding, whereas patients that died within 
the first few weeks of admission are unlikely to have undergone PEG placement. In 
addition, dysphagic patients surviving beyond the initial acute period who were 
judged unsuitable for PEG placement because of severe impairments and co-
morbidities would have had a high short-term mortality from their poor health status 
combined with ongoing risks of aspiration and poor nutritional intake. This apparent 
positive association between PEG placement and initial survival after stroke has not 
been reported previously and might have been detected because of the large size of 
the national dataset. It is important that clinicians continue to carefully consider the 
prognosis for individual patients when recommending non-oral feeding and remain 
cautious about prognosis beyond the first few months during discussions with 
patients and families.   
 
The data reported here were obtained from national sources containing only 
anonymised cases and limited demographic information, and it was not possible to 
link individuals to other clinical information sources describing stroke characteristics, 
comorbidities and cause of death, or identify recurrent stroke admissions. However, 
as these are state-funded mandatory healthcare and mortality datasets which 
receive information regarding every admission and death across England, they 
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provide the most complete information available at a national level during an 
extended time period. It was impossible to determine the timing of PEG placement 
and how many patients later regained swallowing function. It is likely that patients 
only underwent a PEG procedure on one occasion, but any subsequent re-
admission with a further stroke would have counted as a minor contribution towards 
the ‘no PEG’ group because information governance regulations prevented the 
authors from identifying and excluding them.  
 
CONCLUSION 
Over 11 years PEG insertion rates in English stroke services have fallen, whilst 
survival has improved for all admissions. This is likely to reflect improvements in 
many aspects of stroke care. However it is important to recognise that a large 
proportion of patients undergoing PEG placement still die within 6 and 12 months of 
admission, and a decision to offer permanent non-oral feeding requires careful 
consideration in partnership with patients and carers to agree that the resulting 
quality of life is acceptable.   
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Table 1. Stroke admissions and mortality according to PEG status.   



























2007/08 71566 69909 19357 22285 25654 1657 461 720 908 
    (97.7) (27.7) (31.9) (36.7) (2.3) (27.8) (43.5) (54.8) 
2008/09 73924 72342 18675 21671 25148 1582 385 653 847 
    (97.9) (25.8) (29.9) (34.8) (2.1) (24.3) (41.3) (53.5) 
2009/10 78353 76708 18158 21304 25009 1645 397 673 787 
    (97.9) (23.7) (27.8) (32.6) (2.1) (24.1) (40.9) (47.8) 
2010/11 82863 81194 18055 21258 25044 1669 399 662 803 
    (97.9) (22.2) (26.2) (30.8) (2.0) (23.9) (39.7) (48.1) 
2011/12 85772 84133 17461 20758 24911 1639 362 621 799 
    (98.1) (20.8) (24.7) (29.6) (1.9) (22.1) (37.9) (48.8) 
2012/13 87593 85861 17843 21265 25360 1732 380 654 841 
    (98.0) (20.8) (24.8) (29.5) (1.9) (21.9) (37.7) (48.6) 
2013/14 86837 85006 16956 20254 24383 1831 338 664 905 
    (97.9) (19.9) (23.8) (28.7) (2.1) (18.5) (36.3) (49.4) 
2014/15 87444 85853 17207 20594 24754 1591 301 560 780 
    (98.2) (20.0) (23.9) (28.8) (1.8) (18.9) (35.2) (49.0) 
2015/16 89118 87654 17385 20612 24735 1464 222 465 641 
    (98.4) (19.8) (23.5) (28.2) (1.6) (15.2) (31.8) (43.8) 
2016/17 89389 87919 17151 20374 24526 1470 196 408 607 
    (98.4) (19.5) (23.2) (27.9) (1.6) (13.3) (27.8) (41.3) 
2017/18 90377 89125 17300 20432 24261 1252 153 346 513 
    (98.6) (19.4) (22.9) (27.2) (1.4) (12.2) (27.6) (40.9) 
Overall 923236 905704 195548 230807 273785 17532 3594 6426 8431 






Figure 1: Yearly mortality rates at each time point after stroke according to PEG 
status. 
Figure 2. Mortality without (A) and with (B) a PEG procedure for all stroke 
admissions from April 2007 to March 2018. 
 
 
 
 
 
 
